These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3358 related articles for article (PubMed ID: 13130303)

  • 1. Targeting HIF-1 for cancer therapy.
    Semenza GL
    Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible factor 1 (HIF-1) in cancer.
    Quintero M; Mackenzie N; Brennan PA
    Eur J Surg Oncol; 2004 Jun; 30(5):465-8. PubMed ID: 15135470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.
    Krishnamachary B; Berg-Dixon S; Kelly B; Agani F; Feldser D; Ferreira G; Iyer N; LaRusch J; Pak B; Taghavi P; Semenza GL
    Cancer Res; 2003 Mar; 63(5):1138-43. PubMed ID: 12615733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hypoxia-inducible factor HIF as a new target in cancer research].
    L'Allemain G
    Bull Cancer; 2002 Mar; 89(3):257-60. PubMed ID: 11940464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factors and hypoxic cell death in tumour physiology.
    Bacon AL; Harris AL
    Ann Med; 2004; 36(7):530-9. PubMed ID: 15513303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'The metabolism of tumours': 70 years later.
    Semenza GL; Artemov D; Bedi A; Bhujwalla Z; Chiles K; Feldser D; Laughner E; Ravi R; Simons J; Taghavi P; Zhong H
    Novartis Found Symp; 2001; 240():251-60; discussion 260-4. PubMed ID: 11727934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over expression of hypoxia-inducible factor-1alpha in renal and bladder cancer cells increases tumorigenic potency.
    Kondo Y; Hamada J; Kobayashi C; Nakamura R; Suzuki Y; Kimata R; Nishimura T; Kitagawa T; Kunimoto M; Imura N; Hara S
    J Urol; 2005 May; 173(5):1762-6. PubMed ID: 15821583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated hypoxia-inducible factor-1 DNA binding activity to the vascular endothelial growth factor-A promoter mediates increased vascular permeability in donor lung grafts.
    Abraham D; Krenn K; Seebacher G; Paulus P; Klepetko W; Aharinejad S
    Ann Thorac Surg; 2004 May; 77(5):1751-5. PubMed ID: 15111179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis.
    Zhong H; Semenza GL; Simons JW; De Marzo AM
    Cancer Detect Prev; 2004; 28(2):88-93. PubMed ID: 15068831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1alpha in oral cancer.
    Brennan PA; Mackenzie N; Quintero M
    J Oral Pathol Med; 2005 Aug; 34(7):385-9. PubMed ID: 16011605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment.
    Papandreou I; Krishna C; Kaper F; Cai D; Giaccia AJ; Denko NC
    Cancer Res; 2005 Apr; 65(8):3171-8. PubMed ID: 15833847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF at the crossroads between ischemia and carcinogenesis.
    Paul SA; Simons JW; Mabjeesh NJ
    J Cell Physiol; 2004 Jul; 200(1):20-30. PubMed ID: 15137054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1 as a target for drug development.
    Giaccia A; Siim BG; Johnson RS
    Nat Rev Drug Discov; 2003 Oct; 2(10):803-11. PubMed ID: 14526383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma.
    Jiang CQ; Fan LF; Liu ZS; Qian Q; Xia D; Diao LM; He YM; Ai ZL
    Chin Med J (Engl); 2004 Oct; 117(10):1541-6. PubMed ID: 15498380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumors through the HIF system.
    Ratcliffe PJ; Pugh CW; Maxwell PH
    Nat Med; 2000 Dec; 6(12):1315-6. PubMed ID: 11100107
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
    Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
    Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage infiltration and angiogenesis in human malignancy.
    Knowles H; Leek R; Harris AL
    Novartis Found Symp; 2004; 256():189-200; discussion 200-4, 259-69. PubMed ID: 15027491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of HIF-1 inhibitors as anticancer agents.
    Semenza GL
    Drug Discov Today; 2007 Oct; 12(19-20):853-9. PubMed ID: 17933687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 168.